DB2114930: a randomized, multi‐center, double‐blind, double‐dummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone propionate/salmeterol over 12 weeks in subjects with COPD.

Authors
Category Primary study
Year 2013
This article has no abstract
Epistemonikos ID: 0cde26b9f10256339102e46b7c1f859ec591b1cf
First added on: Sep 04, 2019